Related Experiment Video

Updated: Aug 14, 2026

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein
08:04

Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein

Published on: December 20, 2017

C1q, autoimmunity and apoptosis

Marina Botto1, Mark J Walport

  • 1Division of Medicine, Faculty of Medicine, Imperial College, London, UK.

Immunobiology
|October 25, 2002
PubMed

Insights

Complement component C1q deficiency is strongly linked to systemic lupus erythematosus (SLE). Understanding this link offers insights into immune tolerance and SLE pathogenesis, particularly concerning apoptotic cell clearance.

Area of Science:

  • Immunology
  • Rheumatology

Background:

  • Deficiency in classical complement pathway components correlates with systemic lupus erythematosus (SLE) development.
  • C1q deficiency presents the highest prevalence and most severe SLE manifestations.
  • Complement activation is involved in SLE's inflammatory phase, with deposition in tissues and autoantibody formation against C1q.

Purpose of the Study:

  • To explore the connection between C1q deficiency/consumption and lupus.
  • To examine the relationship between apoptosis and complement in SLE.
  • To review insights from C1q-deficient murine models regarding C1q's role in immune tolerance.

Main Methods:

  • Review of literature on complement deficiencies and SLE.
  • Analysis of the role of complement in autoimmune inflammation.
  • Examination of data from murine models of C1q deficiency.

Main Results:

  • C1q deficiency is a significant risk factor for SLE.
  • Complement consumption occurs during SLE inflammation.
  • C1q may play a crucial role in the immune response to apoptotic cell-derived antigens.

Conclusions:

  • C1q's role in immune tolerance and SLE pathogenesis is critical.
  • Understanding C1q deficiency aids in comprehending SLE.
  • C1q influences the immune response to self-antigens from apoptotic cells.

More Related Videos

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

Evaluation of Caspase Activation to Assess Innate Immune Cell Death10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...